Variant report
Variant | esv3497011 |
---|---|
Chromosome Location | chr11:104315142-104321890 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CASP12-1 | chr11:104316596-104316740 | ENSG00000256422 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567845059 | chr11:104315193-104315194 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185880289 | chr11:104315262-104315263 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142557001 | chr11:104315265-104315266 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567077081 | chr11:104315348-104315349 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs71484360 | chr11:104315359-104315360 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs368236421 | chr11:104315421-104315422 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190355238 | chr11:104315461-104315462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182126771 | chr11:104315499-104315500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150641349 | chr11:104315509-104315510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554976379 | chr11:104315536-104315537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574635457 | chr11:104315550-104315551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540530585 | chr11:104315576-104315577 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139731087 | chr11:104315616-104315617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111597396 | chr11:104315622-104315623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144695192 | chr11:104315623-104315624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11226364 | chr11:104315707-104315708 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs35965666 | chr11:104315808-104315809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs71964514 | chr11:104315809-104315810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs71467222 | chr11:104315827-104315828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79823329 | chr11:104315828-104315829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78696297 | chr11:104315833-104315834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371552338 | chr11:104315836-104315837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531336151 | chr11:104315863-104315864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188642042 | chr11:104315878-104315879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561761230 | chr11:104315970-104315971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145706387 | chr11:104315973-104315974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1487695 | chr11:104316004-104316005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181046532 | chr11:104316050-104316051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185080516 | chr11:104316090-104316091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369826836 | chr11:104316141-104316142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552837982 | chr11:104316189-104316190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76341475 | chr11:104316207-104316208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140924889 | chr11:104316221-104316222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369981550 | chr11:104316234-104316235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191205895 | chr11:104316288-104316289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371769823 | chr11:104316293-104316294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375051141 | chr11:104316331-104316332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533818710 | chr11:104316336-104316337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553667378 | chr11:104316339-104316340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576763529 | chr11:104316341-104316342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545574149 | chr11:104316342-104316343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562392690 | chr11:104316356-104316357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575726635 | chr11:104316377-104316378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552772044 | chr11:104316380-104316381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573028327 | chr11:104316391-104316392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561476893 | chr11:104316465-104316466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13377505 | chr11:104316488-104316489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182531061 | chr11:104316497-104316498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142383032 | chr11:104316518-104316519 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532883195 | chr11:104316519-104316520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:104314000-104315600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr11:104314200-104316000 | Enhancers | Fetal Heart | heart |
3 | chr11:104314400-104315600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr11:104314400-104315600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
5 | chr11:104314600-104315600 | Weak transcription | Fetal Lung | lung |
6 | chr11:104314600-104323200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr11:104315000-104316800 | Enhancers | Stomach Mucosa | stomach |
8 | chr11:104315600-104315800 | Enhancers | Fetal Lung | lung |
9 | chr11:104316000-104320200 | Weak transcription | Fetal Heart | heart |
10 | chr11:104316800-104321400 | Weak transcription | Stomach Mucosa | stomach |
11 | chr11:104319400-104320200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr11:104320200-104320600 | Enhancers | Fetal Heart | heart |
13 | chr11:104320200-104322000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr11:104320600-104320800 | Weak transcription | Fetal Heart | heart |
15 | chr11:104320800-104321800 | Enhancers | Fetal Heart | heart |
16 | chr11:104321400-104322800 | Enhancers | Stomach Mucosa | stomach |
17 | chr11:104321800-104322200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
18 | chr11:104321800-104322200 | Flanking Active TSS | Fetal Heart | heart |